FTC Requests Further Information on Potential Pfizer Takeover of Seagen


Demand comes among antitrust agency’s recent denial of Amgen’s Horizon buyout.

Flag of the United States Federal Trade Commission along with a flag of the United States of America as a symbol of a connection between them, 3d illustration. Image Credit: Adobe Stock Images/GoodIdeas

Image Credit: Adobe Stock Images/GoodIdeas

The Federal Trade Commission (FTC) has asked for more information on Pfizer’s proposed $43 billion takeover of Seagan, a biotechnology company. The request, which comes after the agency’s shutdown of Amgen’s attempt to purchase Horizon Therapeutics for $27.8 billion, has made investors skittish at the potential outcome.

Despite the request, Seagan continues to expect its merger with Pfizer will be completed in late 2023 or early 2024.

Reference: US FTC Seeks Additional Info on Pfizer's Proposed Takeover of Seagen. Reuters. July 14, 2023. Accessed July 17, 2023. https://www.reuters.com/markets/deals/us-ftc-seeks-additional-info-pfizers-proposed-takeover-seagen-2023-07-14/

Related Videos
Related Content